RESMED INC — Director's Dealing 2023

Aug 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-08-17

Reporting Person: BLAISE LUCILE (President, Sleep & RC Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-17	ResMed Common Stock	A	819	—	Acquired	7441	Direct
2023-08-17	ResMed Common Stock	A	3294	—	Acquired	10735	Direct

Footnotes

F1: Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on August 17, 2023, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.

F2: Represents performance-based restricted stock units granted on July 1, 2022. The shares were earned on August 17, 2023, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.